Your search returned 3 results.

Results
	1.	Why is CLL refractory to bortezomib? [electronic resource] by Wickremasinghe, Ranmohan Gitendra Producer: 20081112 In: Blood vol. 112 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C. [electronic resource] by Virchis, Andres Ganeshaguru, Kanagasabai Hart, Steve Jones, Dylan Fletcher, Linda Wright, Faith Wickremasinghe, Ranmohan Man, Anthony Csermak, Katalin Meyer, Thomas Fabbro, Doriano Champain, Kate Yap, Alan Prentice, H Grant Mehta, Atul Producer: 20030725 In: The hematology journal : the official journal of the European Haematology Association vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. [electronic resource] by Ganeshaguru, Kanagasabai Wickremasinghe, Ranmohan G Jones, Dylan T Gordon, Mathew Hart, Steve M Virchis, Andres E Prentice, H Grant Hoffbrand, A Victor Man, Anthony Champain, Kate Csermak, Katalin Mehta, Atul B Producer: 20020415 In: Haematologica vol. 87 Availability: No items available. Save to lists Add to cart (remove)

Refine your search